SI

Steven Idell

University Of Texas System: 10 patents #205 of 6,559Top 4%
AT Actuate Therapeutics: 1 patents #4 of 5Top 80%
📍 Tyler, TX: #25 of 403 inventorsTop 7%
🗺 Texas: #13,747 of 125,132 inventorsTop 15%
Overall (All Time): #444,654 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12173089 Inhibition of pulmonary fibrosis with nutlin-3A and peptides Sreerama SHETTY 2024-12-24
12083098 Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors Torry A. Tucker 2024-09-10
11780879 Inhibition of pulmonary fibrosis with nutlin-3A and peptides Sreerama SHETTY 2023-10-10
11161875 Inhibition of pulmonary fibrosis with nutlin-3a and peptides Sreerama SHETTY 2021-11-02
11033611 Compositions and methods for administration of an enzyme to a subject's airway Robert O. WILLIAMS, III 2021-06-15
10377796 Inhibition of pulmonary fibrosis with nutlin-3a and peptides Sreerama SHETTY 2019-08-13
10175255 Fibrinolytic potential: a test of pleural fluid to predict outcomes and guide dosing in fibrinolytic therapy Andrey A. Komissarov, Galina Florova 2019-01-08
9808505 Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR) Usha R. Pendurthi, Vijaya M. Lella, Shivakeshava Gaddam 2017-11-07
9630990 Inhibition of pulmonary fibrosis with nutlin-3A and peptides Sreerama SHETTY 2017-04-25
8697840 Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis Sreerama SHETTY 2014-04-15
7332469 Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions 2008-02-19